# Aurolife Pharma, LLC – FDA Inspection, Jun 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/aurolife-pharma-llc/af02282b-baad-459c-ab27-5f81e3b9e7be
Source feed: FDA_Inspections

> FDA inspection 1055912 of Aurolife Pharma, LLC, June 14, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055912
- Company Name: Aurolife Pharma, LLC
- Inspection Date: 2018-06-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1158258 - 2021-12-07](https://www.keypedia.com/records/fda_inspections/aurolife-pharma-llc/b5941257-91bb-4441-8ba8-f35bfcc3ecea)
- FDA Inspection 1109452 - 2019-10-22
- FDA Inspection 980107 - 2016-07-28
- FDA Inspection 952634 - 2016-01-12
- FDA Inspection 933659 - 2015-07-09

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/adetutu-m-gidado/6c4e8cf3-0eea-4903-9ca5-e8e2d683621d)
- [FDA Associated Person](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)

Company: https://www.keypedia.com/companies/aurolife-pharma-llc/b82a0c8c-6b52-4624-8c6c-21887615bc7d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
